Hester Biosciences gets nod to raise funds up to Rs 100 crore

13 Aug 2018 Evaluate

Hester Biosciences has received an approval for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 100 crore. The Board of Directors of the company at their meeting held on August 10, 2018, approved the same.

The Board also approved borrowings as a loan to the extent of $10 million under External Commercial Borrowing (ECB) as per guidelines issued by Reserve Bank of India.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×